FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...

Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + ...

This article is brought to you by Ochsner Health. While overall rates of colorectal cancer have been declining in the United States, the numbers have been steadily increasing among younger patients.

CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...

Most people with colon cancer begin treatment by having surgery to remove their cancer. If colon cancer has spread beyond your colon, you might have chemotherapy first. This can help treat cancer ...

A new report found that colorectal cancer causes more deaths than any other type of cancer, including breast and lung cancers ...

Fewer people under age 50 are dying from cancer in the U.S., but colorectal cancer mortality rates continue to surge ...

Colon cancer symptoms often don't exist. An active woman shares how repeated nudges from a loved one led to her diagnosis: "My entire life changed that day." ...

While overall rates of colorectal cancer have been declining in the United States, the numbers have been steadily increasing among younger patients. In fact, 1 out of 8 cancer patients treated for ...